Besremi info

[wateron]

businesswire.com/news/home/...

[PhysAssist]

That looks good and makes some sense- especially:

"Across the studies, ropeginterferon alfa-2b was generally well-tolerated. No thromboembolic complications have been reported with the accelerated titration regimen in PV. Rather, the review authors indicate that it is reasonable to believe that the accelerated dosing regimen may potentially minimize the risk of thrombosis and hemorrhage associated with an under-dosing during dose titrations."

I'm just up to 350 mcg every other weeks now, after starting in 10/22.

I will certainly be forwarding the report to my MPN/Onco specialist and her Onco-Pharmacist. ASAP.

Thanks so much for finding and posting it!

Best,

PA